2020 NATIONAL CONSCIOUSNESS WEEK AGAINST COUNTERFEIT MEDICINES (NCWACM)
16 to 20 November 2020
You’re welcome po. For the facebook po, I can only give the link po for the whole program proper that were streamed last monday. Here’s the link
https://fb.watch/1RKgD6UJiu/
PLS GO TO 35th minute .
Program of Activities
16 NOVEMBER 2020 (OPENING)
Moderator: Dir. Jesusa Joyce N. Cirunay, Center for Drug Regulation and Research, FDA Philippines
8:00 AM – 8:20 AM Welcome Address Hon. Francisco T. Duque III, MSc
Secretary of Health, Department of Health (DOH)
8:20 AM – 8:40 AM Opening Remarks Rolando Enrique D. Domingo, MD
Director General, Food and Drug
Administration (FDA) Philippines
8:40 AM – 9:00 AM Messages from Partners Atty. Victorio Mario A. Dimagiba President, Laban Konsyumer, Inc.
(Consumer Group)
Dr. Beaver R. Tamesis
President, Pharmaceutical & Healthcare Association of the Philippines (PHAP)
(Industry)
Undersecretary Ruth B. Castelo
Consumer Protection Group, Department of Trade and Industry (DTI)
(Government)
9:00 AM – 9:30 AM Global efforts on the fight against counterfeit medicines (Pre-recorded) Diana A. Lee
Technical Officer, Incidents and
Substandard/Falsified Medical Products
(ISF), Regulation and Safety, World
Health Organization (WHO)
9:30 AM – 10:00 AM Product Verification process of the Center for Drug Regulation and Research of the
FDA Jesusa Joyce N. Cirunay, RPh
Director IV, Center for Drug Regulation and Research, FDA Philippines
10:00 AM – 10:30 AM Online Poll or Quiz (e.g., determine if counterfeit or not) Moderator
10:30 AM – 11:00 AM Question and Answer (chat-box only)
11:00 AM – 11:30 AM Synthesis and Closing
17 NOVEMBER 2020 (ENFORCEMENT)
Moderator: Dir. Gomel C. Gabuna, Field Regulatory Operations Office, FDA Philippines
8:00 AM – 8:30 AM Field experience in combatting counterfeit products in the digital age Arra M. Tecson
Theme: “Sa Gitna ng Pandemya, Magtulungan Laban sa Pekeng Medisina”
Special Investigator II, Regulatory
Enforcement Unit-South Luzon Cluster, FDA Philippines
8:30 AM – 9:00 AM Local experience on combatting counterfeits or related activities Bayani M. Razalan
Police Colonel, Criminal Investigation and Detection Group-Anti-Fraud and
Commercial Crime Unit (CIDG-AFCCU),
Camp Crame, Quezon City (Local)
9:00 AM – 9:30 AM International experience on combatting counterfeits or related activities and elements of violations against Republic Act (RA) No. 8203 Joey B. Moran
Executive Officer, International Operations
Division (IOD)-National Bureau of Investigation (NBI)
(International)
9:30 AM – 10:00 AM Online Poll or Quiz (e.g., if permitted such as Chinese characters on labels, peddlers, online platforms) Moderator
10:00 AM – 10:30 AM Question and Answer (chat-box only)
10:30 AM – 11:00 AM Synthesis and Closing
18 NOVEMBER 2020 (LEGAL)
Moderator: Atty. Katherine M. Austria-Lock, Legal Services Support Center, FDA Philippines
8:00 AM – 8:30 AM Salient points of RA 8203 and the legal experiences of FDA in enforcing the law Atty. Vanessa G. Legasto
Attorney IV, Legal Services Support Center, FDA
8:30 AM – 9:45 AM The activities and programs of the
Department of Justice (DOJ) Task Force in its fight against counterfeit medicines, including procedure in filing criminal cases in violation of RA 8203 Deputy City Prosecutor Noemi L.
Suavillo-Macababbad
Office of the Chief Prosecutor, Muntinlupa City
9:45 AM – 10:15 AM Online Poll or Quiz (e.g., determine if a crime or not) Moderator
10:15 AM – 10:45 AM Question and Answer (chat-box only)
10:45 AM – 11:15 AM Synthesis and Closing
19 NOVEMBER 2020 (ADVOCACY/EDUCATION)
Moderator: Dir. Annette B. Tan, Field Regulatory Operations Office, FDA Philippines
8:00 – 8:10 AM Opening Moderator
8:10 – 8:25 AM Setting the scene
Getting to know the actors
8:25 – 8:35 AM Advocacy campaigns of the FDA to increase awareness on Counterfeit Medicines Gabrielle S. Gabriel
Policy and Planning Services, FDA Philippines
8:35 – 8:50 AM The Pharmaceutical Industry Marcel de Grutter
Liaison Regulatory & Government Affairs, Global Supply Chain, Established
Page 2 of 3
Pharmaceuticals Division, Abbott Healthcare Products, Netherlands 8:50 – 9:05 AM The pharmacy & the community and institutional pharmacists Fatima May R. Tesoro
Dean, Pharmacy Department,
San Pedro College (SPC), Davao City
9:05 – 9:20 AM The industrial and regulatory pharmacist Bienvenido S. Balotro, RPh, MBA, MS
Dean, College of Pharmacy,
University of the Philippines-Manila
9:20 – 9:50 AM Reactions and Live Q&A Moderator
9:50 – 10:05 AM Break
The digital age and the new normal
10:05 – 10:20 AM Features of the pharmacy curriculum integrating quality medicines assessment Alicia P. Catabay, RPh, MSc, PhD
Dean, College of Pharmacy,
De La Salle Medical and Health Sciences Institute (DLSMHSI)
10:20 – 10:35 AM Incorporating internet or online pharmacy into teaching Good Dispensing Practices Lordwin Alexis C. Labuguen RPh,
BSCP
Faculty, Department of Pharmacy, School of Natural Sciences, Saint Louis University (SLU), Baguio City
10:35 – 10:50 AM Elevating pharmacy services to address counterfeit medicines in the new normal Remi Charlene M. Salvilla, RPh, PhD
Academic Supervisor for Pharmacy,
College of Health and Allied Medical
Professions, University of San Agustin (USA), Iloilo City
10:50 – 11:20 AM Reactions and Live Q&A Moderator
11:20 – 11:30 AM Synthesis and Closing
20 NOVEMBER 2020 (CLOSING)
Moderator: Dir. Deborah S. Legaspi, Field Regulatory Operations Office, FDA Philippines
8:00 AM – 8:30 AM Review of the week-long celebration Jesusa Joyce N. Cirunay, RPh
Director IV, Center for Drug Regulation and Research, FDA Philippines
8:30 AM – 9:00 AM FDA updates on the Anti-Red Tape Act Lyn May E. Balmes
Policy and Planning Services, FDA Philippines
9:00 AM – 9:30 AM Question and Answer (chat-box only) Moderator
9:30 AM – 10:00 AM Announcement of Winners
10:00 AM – 10:30 AM Turn-over to the FROO of the NCWACM Celebration for CY 2021
10:30 AM – 11:00 AM Acknowledgement for the TWG,
NCWACM team, and other stakeholders
11:00 AM – 11:30 AM Closing Remarks
Page 3 of 3